Hydroxychloroquine and azithromycin as a treatment of COVID-19

被引:0
|
作者
Alice Fanin
Jessica Calegari
Anna Beverina
Silvia Tiraboschi
机构
[1] Università degli Studi di Milano,Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
[2] Università degli Studi di Milano,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:841 / 843
页数:2
相关论文
共 50 条
  • [21] Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
    Alizargar, Javad
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 38
  • [22] Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
    Mori, Nobuaki
    Katayama, Mitsuya
    Nukaga, Shigenari
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (01) : 109 - 112
  • [23] Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial
    Abbas, Hassan M.
    Al-Jumaili, Ali Azeez
    Nassir, Kawthar F.
    Al-Obaidy, Muhammed Waheeb
    Al Jubouri, Adnan Mohammed
    Dakhil, Basim Dhawi
    Abdulelah, Mohammed Mahir
    Al Khames, Qutaiba Ahmed
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
  • [24] Reply to: "QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights"
    Hummel, James P.
    Akar, Joseph G.
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (10) : 2795 - 2795
  • [25] Electrocardiograms of a COVID-19 patient treated with the combination of hydroxychloroquine and azithromycin
    Benouna, Mohamed Elghali
    Ech-Chenbouli, Amine
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2020, 35
  • [26] Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
    Lamback, Elisa Baranski
    de Oliveira, Monica Amorim
    Haddad, Andrea Ferreira
    Marcondes Vieira, Andre Filipe
    Ferreira Neto, Armando Leao
    Maia, Taciana da Silva
    Chrisman, Juliana de Rezende
    de Mello Spineti, Pedro Pimenta
    de Mattos, Marco Antonio
    Costa, Eduardo
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2021, 25 (02):
  • [27] HYDROXYCHLOROQUINE AND AZITHROMYCIN COMBINATION COULD BE LETHAL TO COVID-19 PATIENTS
    Mohammad, Firdous Sayeed
    Karmakar, Varnita
    Irfan, Zainab
    [J]. FARMACIA, 2020, 68 (03) : 384 - 389
  • [28] Hydroxychloroquine/azithromycin in COVID-19: The association between time to treatment and case fatality rate
    Alfonso Accinelli, Roberto
    Jesus Ynga-Melendez, Grisel
    Alonso Leon-Abarca, Juan
    Marianella Lopez, Lidia
    Carlos Madrid-Cisneros, Juan
    Diego Mendoza-Saldana, Juan
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 44
  • [29] Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19
    Ozdemir, Ibrahim Halil
    Ozlek, Bulent
    Ozen, Mehmet Burak
    Gunduz, Ramazan
    cetin, Nurullah
    Bilge, Ali Riza
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (02)
  • [30] Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish
    Mendonca-Gomes, Juliana Moreira
    da Costa Araujo, Amanda Pereira
    da Luz, Thiarlen Marinho
    Charlie-Silva, Ives
    Bezerra Braz, Helyson Lucas
    Bezerra Jorge, Roberta Jeane
    Ahmed, Mohamed Ahmed Ibrahim
    Nobrega, Rafael Henrique
    Vogel, Christoph F. A.
    Malafaia, Guilherme
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 790